Biological Standarization of Cupressus Arizonica Allergen Extract to Determine the Biological Activity in Histamine Equivalent Units (HEP)
Phase of Trial: Phase II
Latest Information Update: 23 Jun 2016
At a glance
- Drugs Cupressus arizonica pollen allergy immunotherapy-Laboratorios-Leti (Primary)
- Indications Tree pollen hypersensitivity
- Focus Diagnostic use
- Sponsors Laboratorios LETI
- 17 Jun 2016 Status changed from active, no longer recruiting to completed.
- 15 Dec 2015 Status changed from recruiting to active, no longer recruiting, according to ClinicalTrials.gov record.
- 13 Aug 2015 New trial record